243 related articles for article (PubMed ID: 18721582)
1. The treatment of patients with stage IIIA non-small cell lung cancer from N2 disease: who returns to the surgical arena and who survives.
Cerfolio RJ; Maniscalco L; Bryant AS
Ann Thorac Surg; 2008 Sep; 86(3):912-20; discussion 912-20. PubMed ID: 18721582
[TBL] [Abstract][Full Text] [Related]
2. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2008 Aug; 86(2):362-6; discussion 366-7. PubMed ID: 18640297
[TBL] [Abstract][Full Text] [Related]
3. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study.
Cerfolio RJ; Bryant AS; Ojha B
J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1229-35. PubMed ID: 16733150
[TBL] [Abstract][Full Text] [Related]
4. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.
Martin LW; Correa AM; Hofstetter W; Hong WK; Komaki R; Putnam JB; Rice DC; Smythe WR; Swisher SG; Vaporciyan AA; Walsh GL; Roth JA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1601-10. PubMed ID: 16308005
[TBL] [Abstract][Full Text] [Related]
5. Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer?
Park BB; Park JO; Kim H; Ahn YC; Choi YS; Kim K; Kim J; Shim YM; Ahn JS; Park K
Lung Cancer; 2006 Sep; 53(3):323-30. PubMed ID: 16844258
[TBL] [Abstract][Full Text] [Related]
6. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
7. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
[TBL] [Abstract][Full Text] [Related]
8. Predictors of survival and disease-free survival in patients with resected N1 non-small cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2007 Jul; 84(1):182-8; discussion 189-90. PubMed ID: 17588408
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary resection after concurrent chemotherapy and high dose (60Gy) radiation for non-small cell lung cancer is safe and may provide increased survival.
Cerfolio RJ; Bryant AS; Jones VL; Cerfolio RM
Eur J Cardiothorac Surg; 2009 Apr; 35(4):718-23; discussion 723. PubMed ID: 19233668
[TBL] [Abstract][Full Text] [Related]
10. Non-small cell lung carcinoma of the superior sulcus: favourable outcomes of combined modality treatment in carefully selected patients.
Kappers I; Belderbos JS; Burgers JA; van Zandwijk N; Groen HJ; Klomp HM
Lung Cancer; 2008 Mar; 59(3):385-90. PubMed ID: 17913281
[TBL] [Abstract][Full Text] [Related]
11. Survival of patients with true pathologic stage I non-small cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920
[TBL] [Abstract][Full Text] [Related]
12. Accessing the aortopulmonary window (#5) and the paraaortic (#6) lymph nodes in patients with non-small cell lung cancer.
Cerfolio RJ; Bryant AS; Eloubeidi MA
Ann Thorac Surg; 2007 Sep; 84(3):940-5. PubMed ID: 17720403
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in resected pathologic (p-) stage IIIA-N2, non-small-cell lung cancer.
Tanaka F; Yanagihara K; Otake Y; Kawano Y; Miyahara R; Takenaka K; Katakura H; Ishikawa S; Ito H; Wada H
Ann Surg Oncol; 2004 Jun; 11(6):612-8. PubMed ID: 15150069
[TBL] [Abstract][Full Text] [Related]
14. [RAdio-chemo-surgical combined treatment of non-small cell lung carcinoma N2].
Rovea P; Sola B; Boidi Trotti A; Gabriele AM; Fracchia F; Casadio C; Bretti S
Radiol Med; 1993 Jun; 85(6):840-3. PubMed ID: 8393206
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of superior sulcus tumors: results and prognostic factors.
Demir A; Sayar A; Kocaturk CI; Gunluoglu MZ; Akýn H; Metin M; Cansever L; Olcmen A; Dincer SI; Bedirhan MA; Gurses A
Thorac Cardiovasc Surg; 2009 Mar; 57(2):96-101. PubMed ID: 19241311
[TBL] [Abstract][Full Text] [Related]
16. Surgical therapy for carcinoma of the lung.
Shields TW
Clin Chest Med; 1993 Mar; 14(1):121-47. PubMed ID: 8384959
[TBL] [Abstract][Full Text] [Related]
17. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
[TBL] [Abstract][Full Text] [Related]
18. Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer.
Higgins K; Chino JP; Marks LB; Ready N; D'Amico TA; Clough RW; Kelsey CR
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1462-7. PubMed ID: 19467798
[TBL] [Abstract][Full Text] [Related]
19. [Stage III NSCLC. The surgeon's role in exploration and treatment].
van Schil P; de Waele M; Hendriks J; Lauwers P
Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S88-94. PubMed ID: 18971831
[TBL] [Abstract][Full Text] [Related]
20. Chest wall invasion in non-small cell lung carcinoma: a rationale for en bloc resection.
Facciolo F; Cardillo G; Lopergolo M; Pallone G; Sera F; Martelli M
J Thorac Cardiovasc Surg; 2001 Apr; 121(4):649-56. PubMed ID: 11279404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
